M4 Organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 3, 2017
April 24, 2020
e5a79d19-73aa-4d4c-baa8-342b5ddc7632
Related Documents
Prescription Drug User Fee Act Waivers, Reductions, and Refunds for Drug and Biological Products Guidance for Industry
Guidance DocumentOctober 17, 2019Center for Drug Evaluation and Research
S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers
Guidance DocumentMarch 8, 2010Center for Drug Evaluation and Research
E2C(R2) Periodic Benefit-Risk Evaluation Report – Questions and Answers
Guidance DocumentJuly 19, 2016Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.